HKSE:09960 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:09960 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kindstar Globalgene Technology's enterprise value is HK$-155 Mil. Kindstar Globalgene Technology's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1,029 Mil. Therefore, Kindstar Globalgene Technology's EV-to-Revenue for today is -0.15.
The historical rank and industry rank for Kindstar Globalgene Technology's EV-to-Revenue or its related term are showing as below:
During the past 6 years, the highest EV-to-Revenue of Kindstar Globalgene Technology was 6.79. The lowest was -1.58. And the median was -0.47.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-12-15), Kindstar Globalgene Technology's stock price is HK$1.14. Kindstar Globalgene Technology's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1.07. Therefore, Kindstar Globalgene Technology's PS Ratio for today is 1.07.
The historical data trend for Kindstar Globalgene Technology's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindstar Globalgene Technology Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EV-to-Revenue | Get a 7-Day Free Trial | - | - | 2.25 | 0.45 | -0.30 |
Kindstar Globalgene Technology Semi-Annual Data | |||||||||||
Dec18 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
EV-to-Revenue | Get a 7-Day Free Trial | - | 0.45 | - | -0.30 | - |
For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Kindstar Globalgene Technology's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Kindstar Globalgene Technology's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | -154.820 | / | 1028.564 | |
= | -0.15 |
Kindstar Globalgene Technology's current Enterprise Value is HK$-155 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1,029 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindstar Globalgene Technology (HKSE:09960) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Kindstar Globalgene Technology's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 1.14 | / | 1.066 | |
= | 1.07 |
Kindstar Globalgene Technology's share price for today is HK$1.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was HK$1.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Kindstar Globalgene Technology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Jackson Hole Trust Company | ||
Huang Bo | ||
Kernelstar Limited | 2301 Trustee | |
Kastle Limited | 2301 Trustee | |
Guo Gui-rong | 2202 Interest of your spouse | |
Huang Shiang | 2101 Beneficial owner | |
Huang Zuie-chin | 2101 Beneficial owner | |
Tu Zanbing | ||
Chan Tan Ching Fen | 2307 Founder of a discretionary trust who can infl | |
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd. | ||
Cpechina Fund Iii, L.p. | 2201 Interest of corporation controlled by you | |
Cpe Holdings Limited | 2201 Interest of corporation controlled by you | |
Cpe Holdings International Limited | 2201 Interest of corporation controlled by you | |
Cpe Funds Iii Limited | 2201 Interest of corporation controlled by you | |
Ck Lab Tech Investment Limited | 2101 Beneficial owner |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.